STOCK TITAN
  1. Home
  2. Sec-filings
  3. EMR
  4. [Form 4] EMERSON ELECTRIC CO Insider Trading Activity

EMR CEO now directly owns 327,915 shares after award activity

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Emerson Electric (EMR) reported insider transactions by President & CEO Surendralal Karsanbhai on 11/03/2025. He acquired 163,588 shares upon payout of earned units under a performance share award pursuant to a shareholder‑approved plan. The company withheld 72,061 shares for required taxes at a fair market value of $139.46 per share. He also received a grant of 54,475 restricted stock units under a shareholder‑approved plan.

After the reported transactions, he directly owned 327,915 shares of common stock. Additional indirect holdings include positions in benefit plans and a trust.

Positive

  • None.

Negative

  • None.
Insider Karsanbhai Surendralal Lanca
Role President & CEO
Type Security Shares Price Value
Grant/Award Common Stock 163,588 $0.00 --
Tax Withholding Common Stock 72,061 $139.46 $10.05M
Grant/Award Common Stock 54,475 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 345,501 shares (Direct); Common Stock — 453.26 shares (Indirect, Custodian Account for Daughter)
Footnotes (1)
  1. Acquisition of shares pursuant to Rile 16b-3 upon payout of 163,588 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2025. Price is not applicable to the acquisition described in Note 1. Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1. Fair market value on date of withholding described in Note 1. Grant to Reporting Person of 54,475 restricted stock units under shareholder approved benefit plan pursuance to Rule 16b-3(d). Price is not applicable to acquisitions resulting from grants of restricted stock units.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Karsanbhai Surendralal Lanca
(Last) (First) (Middle)
C/O EMERSON ELECTRIC CO.
8027 FORSYTH BLVD.
(Street)
ST. LOUIS MO 63105
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EMERSON ELECTRIC CO [ EMR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/03/2025 A(1) 163,588(1) A (2) 345,501 D
Common Stock 11/03/2025 F(3) 72,061(3) D $139.46(4) 273,440 D
Common Stock 11/03/2025 A(5) 54,475(5) A (6) 327,915 D
Common Stock 453.26 I Custodian Account for Daughter
Common Stock 453.26 I Custodian Account for Son
Common Stock 164,957.0331 I By Trust
Common Stock 49.434 I 401(k) excess plan
Common Stock 2,485.557 I 401(k) excess plan II
Common Stock 660.54 I 401(k) plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Acquisition of shares pursuant to Rile 16b-3 upon payout of 163,588 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2025.
2. Price is not applicable to the acquisition described in Note 1.
3. Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1.
4. Fair market value on date of withholding described in Note 1.
5. Grant to Reporting Person of 54,475 restricted stock units under shareholder approved benefit plan pursuance to Rule 16b-3(d).
6. Price is not applicable to acquisitions resulting from grants of restricted stock units.
Remarks:
/s/ John A.. Sperino, Attorney-in-Fact for Surendralal Lanca Karsanbhai 11/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did EMR CEO report on Form 4?

He reported the payout of 163,588 earned units into common shares, tax withholding of 72,061 shares at $139.46, and a grant of 54,475 RSUs.

What is the date of the reported transactions for EMR (EMR)?

The earliest transaction date disclosed is 11/03/2025.

How many EMR shares did the CEO directly own after the transactions?

Direct ownership following the reported transactions was 327,915 shares.

How were the 163,588 EMR shares acquired?

They were acquired upon payout of earned units under a performance share award pursuant to a shareholder‑approved plan.

Why were 72,061 EMR shares disposed of at $139.46?

They were withheld for required minimum taxes upon vesting; the value used was the fair market value of $139.46 on the withholding date.

What additional equity was granted to the CEO?

A grant of 54,475 restricted stock units was reported under a shareholder‑approved plan.